Annual revenue:
$0.00$0.00(0.00%)Summary
- As of today (September 10, 2025), XENE annual revenue is $0.00, unchanged on December 31, 2024.
- During the last 3 years, XENE annual revenue has fallen by -$18.44 million (-100.00%).
- XENE annual revenue is now -100.00% below its all-time high of $32.17 million, reached on December 31, 2020.
Performance
XENE Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$0.00-$7.50M(-100.00%)Summary
- As of today (September 10, 2025), XENE quarterly revenue is $0.00, with the most recent change of -$7.50 million (-100.00%) on June 1, 2025.
- Over the past year, XENE quarterly revenue has stayed the same.
- XENE quarterly revenue is now -100.00% below its all-time high of $13.38 million, reached on June 30, 2020.
Performance
XENE Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$7.50M$0.00(0.00%)Summary
- As of today (September 10, 2025), XENE TTM revenue is $7.50 million, unchanged on June 1, 2025.
- Over the past year, XENE TTM revenue has increased by +$7.50 million (+100.00%).
- XENE TTM revenue is now -76.68% below its all-time high of $32.17 million, reached on December 31, 2020.
Performance
XENE TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
XENE Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | 0.0% | 0.0% | +100.0% |
| 3 y3 years | -100.0% | -100.0% | -64.6% |
| 5 y5 years | -100.0% | -100.0% | -72.5% |
XENE Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | at low | -100.0% | at low | -64.6% | >+9999.0% |
| 5 y | 5-year | -100.0% | at low | -100.0% | at low | -76.7% | >+9999.0% |
| alltime | all time | -100.0% | at low | -100.0% | at low | -76.7% | >+9999.0% |
XENE Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $0.00(-100.0%) | $7.50M(0.0%) |
| Mar 2025 | - | $7.50M(>+9900.0%) | $7.50M(>+9900.0%) |
| Dec 2024 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2024 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2024 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2024 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2023 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2023 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Jun 2023 | - | $0.00(0.0%) | $132.00K(-80.2%) |
| Mar 2023 | - | $0.00(0.0%) | $668.00K(-92.9%) |
| Dec 2022 | $9.43M(-48.8%) | $0.00(-100.0%) | $9.43M(-28.4%) |
| Sep 2022 | - | $132.00K(-75.4%) | $13.17M(-37.8%) |
| Jun 2022 | - | $536.00K(-93.9%) | $21.16M(-7.4%) |
| Mar 2022 | - | $8.77M(+134.6%) | $22.84M(+23.9%) |
| Dec 2021 | $18.44M(-42.7%) | $3.74M(-54.0%) | $18.44M(-7.1%) |
| Sep 2021 | - | $8.12M(+266.3%) | $19.85M(+8.6%) |
| Jun 2021 | - | $2.22M(-49.1%) | $18.28M(-37.9%) |
| Mar 2021 | - | $4.36M(-15.4%) | $29.45M(-8.5%) |
| Dec 2020 | $32.17M(+371.0%) | $5.15M(-21.4%) | $32.17M(+6.0%) |
| Sep 2020 | - | $6.55M(-51.0%) | $30.34M(+11.2%) |
| Jun 2020 | - | $13.38M(+89.1%) | $27.29M(+96.2%) |
| Mar 2020 | - | $7.08M(+112.6%) | $13.91M(+103.6%) |
| Dec 2019 | $6.83M | $3.33M(-4.9%) | $6.83M(+95.1%) |
| Sep 2019 | - | $3.50M(>+9900.0%) | $3.50M(>+9900.0%) |
| Jun 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2018 | - | $0.00(0.0%) | $16.00K(-94.3%) |
| Jun 2018 | - | $0.00(0.0%) | $280.00K(-5.1%) |
| Mar 2018 | - | $0.00(-100.0%) | $295.00K(-5.1%) |
| Dec 2017 | $311.00K(-82.8%) | $16.00K(-93.9%) | $311.00K(-53.7%) |
| Sep 2017 | - | $264.00K(+1660.0%) | $671.00K(-18.2%) |
| Jun 2017 | - | $15.00K(-6.3%) | $820.00K(-32.7%) |
| Mar 2017 | - | $16.00K(-95.7%) | $1.22M(-32.4%) |
| Dec 2016 | $1.80M(-88.4%) | $376.00K(-9.0%) | $1.80M(-61.3%) |
| Sep 2016 | - | $413.00K(0.0%) | $4.65M(-45.5%) |
| Jun 2016 | - | $413.00K(-31.3%) | $8.54M(-29.9%) |
| Mar 2016 | - | $601.00K(-81.4%) | $12.17M(-21.9%) |
| Dec 2015 | $15.58M(-45.1%) | $3.23M(-24.8%) | $15.58M(-9.6%) |
| Sep 2015 | - | $4.29M(+6.1%) | $17.23M(-34.1%) |
| Jun 2015 | - | $4.05M(+0.9%) | $26.13M(-4.6%) |
| Mar 2015 | - | $4.01M(-17.8%) | $27.38M(-3.5%) |
| Dec 2014 | $28.37M(+3.7%) | $4.88M(-63.0%) | $28.37M(-2.4%) |
| Sep 2014 | - | $13.19M(+149.0%) | $29.07M(+9.0%) |
| Jun 2014 | - | $5.30M(+5.9%) | $26.67M(+24.8%) |
| Mar 2014 | - | $5.00M(-10.4%) | $21.37M(+30.5%) |
| Dec 2013 | $27.36M(+91.2%) | $5.58M(-48.2%) | $16.37M(+51.8%) |
| Sep 2013 | - | $10.79M | $10.79M |
| Dec 2012 | $14.31M(+106.8%) | - | - |
| Dec 2011 | $6.92M | - | - |
FAQ
- What is Xenon Pharmaceuticals Inc. annual revenue?
- What is the all time high annual revenue for Xenon Pharmaceuticals Inc.?
- What is Xenon Pharmaceuticals Inc. annual revenue year-on-year change?
- What is Xenon Pharmaceuticals Inc. quarterly revenue?
- What is the all time high quarterly revenue for Xenon Pharmaceuticals Inc.?
- What is Xenon Pharmaceuticals Inc. quarterly revenue year-on-year change?
- What is Xenon Pharmaceuticals Inc. TTM revenue?
- What is the all time high TTM revenue for Xenon Pharmaceuticals Inc.?
- What is Xenon Pharmaceuticals Inc. TTM revenue year-on-year change?
What is Xenon Pharmaceuticals Inc. annual revenue?
The current annual revenue of XENE is $0.00
What is the all time high annual revenue for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high annual revenue is $32.17M
What is Xenon Pharmaceuticals Inc. annual revenue year-on-year change?
Over the past year, XENE annual revenue has changed by $0.00 (0.00%)
What is Xenon Pharmaceuticals Inc. quarterly revenue?
The current quarterly revenue of XENE is $0.00
What is the all time high quarterly revenue for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high quarterly revenue is $13.38M
What is Xenon Pharmaceuticals Inc. quarterly revenue year-on-year change?
Over the past year, XENE quarterly revenue has changed by $0.00 (0.00%)
What is Xenon Pharmaceuticals Inc. TTM revenue?
The current TTM revenue of XENE is $7.50M
What is the all time high TTM revenue for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high TTM revenue is $32.17M
What is Xenon Pharmaceuticals Inc. TTM revenue year-on-year change?
Over the past year, XENE TTM revenue has changed by +$7.50M (+100.00%)